Ovarian cancer and the immune system

Abstract

Short communication in response to the review of Turner et al. entitled “Ovarian cancer and the immune system - the role of targeted therapies” published in Gynecological Oncology. We believe systemic immune parameters might be a good alternative to tumor biopsy to gain insight in the immunological background of ovarian cancer.

Keywords

• Ovarian cancer
• Immune system
• Regulatory T cell
• Myeloid derived suppressor cell
• Liquid biopsy